methimazole and Escherichia-coli-Infections

Biofilms that are widely associated with persistent bacterial infections impose a heavy burden on patients primarily due to their formidable resistance to conventional antiseptic drugs and local immune defense. Here, we successfully synthesized functional gold nanocomposites (CS-Au@MMT) by reducing chloroauric acid in the presence of biocompatible chitosan polymers with cationic amine and the small molecule 2-mercapto-1-methylimidazole (MMT). The cationic amine allowed transport of the CS-Au@MMT to the negatively charged sites at the surface of bacterial cells though electrostatic adhesion, with synergistic effects from the gold nanoparticles and MMT then exerting a strong bactericidal effect to inhibit biofilm formation. For established mature biofilms, CS-Au@MMT was able to adhere to the biofilm surface to render nearby bacterial cells inactive, resulting in biofilm rupture. This allowed CS-Au@MMT to penetrate through the biofilm, leading to sustained damage and achieving biofilm elimination. Furthermore, the nanocomposites efficiently inhibited infections induced by mature biofilm in vivo. These findings indicated that the CS-Au@MMT nanocomposites provide ease of synthesis and fabrication, high bactericidal effect, and low toxicity; thus, they show potential as biofilm-disrupting agents for biomedical and industrial applications.

Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Chitosan; Escherichia coli; Escherichia coli Infections; Gold; Humans; Imidazoles; Mice; Nanocomposites; Staphylococcal Infections; Staphylococcus aureus

Topics: Agranulocytosis; Antithyroid Agents; Diagnosis, Differential; Escherichia coli Infections; Female; Follow-Up Studies; Furunculosis; Humans; Methimazole; Middle Aged; Skin Ulcer